Crestline Management’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-28,700
Closed -$492K 174
2017
Q1
$492K Buy
+28,700
New +$492K 0.09% 85